Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study

Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study

Abstract Purpose The pathological diagnosis and prognosis prediction of hepatocellular carcinoma (HCC) is challenging due to the lack of specific biomarkers. This study aimed to validate the diagnostic and prognostic efficiency of Kidney-type glutaminase (GLS1) for HCC in prospective cohorts with a...

Full description

Bibliographic Details
Main Authors: Laizhu Zhang, Ke Su, Qi Liu, Binghua Li, Ye Wang, Chunxiao Cheng, Yunzheng Li, Chun Xu, Jun Chen, Hongyan Wu, Mengxia Zhu, Xiaoli Mai, Yajuan Cao, Jin Peng, Yang Yue, Yitao Ding, Decai Yu
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Cancer
Subjects:
Biomarker
Diagnosis
Glutaminase
Hepatocellular carcinoma
Prognosis
Online Access:https://doi.org/10.1186/s12885-023-11601-y

Internet

https://doi.org/10.1186/s12885-023-11601-y

Similar Items